NYSEAMERICAN:CVRS Corindus Vascular Robotics (CVRS) Stock Price, News & Analysis $4.27 0.00 (0.00%) (As of 11/27/2019) Add Compare Share Share Stock Analysis Stock Analysis Get Corindus Vascular Robotics alerts: Email Address About Corindus Vascular Robotics Stock (NYSEAMERICAN:CVRS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CVRS alerts:Sign Up Key Stats Today's Range$4.27▼$4.2750-Day Range N/A52-Week Range$0.78▼$4.40VolumeN/AAverage Volume1.99 million shsMarket Capitalization$891.08 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCorindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.Read More… How the US Will Win the Great Lithium Race (Ad)China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill.Join GM as an early investor in this company by October 3. Receive CVRS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Corindus Vascular Robotics and its competitors with MarketBeat's FREE daily newsletter. Email Address CVRS Stock News HeadlinesCorindus Vascular Robotics, Inc.March 22, 2024 | thestreet.comHealthCor Partners Fund II, L.P.'s Net WorthFebruary 9, 2024 | benzinga.comHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but it processes 70-80%. Now the US is coming over the top by investing $700B+ into domestic supply with the IRA and Bi-partisan Infrastructure Bill.September 20, 2024 | DealMaker (Ad)Robotics, AI And Cognitive Computing Are Changing Organizations Even Faster Than We ThoughtMay 28, 2023 | forbes.com2023-2030 Robotic Vascular Catheter System Market Size with [94 Pages] includes Growth Rate Analysis | New Report by Absolute ReportsApril 21, 2023 | marketwatch.comRobotics & AIMarch 2, 2023 | techcrunch.comGanymed Robotics Raises Additional €15 M through Series B Extension Bringing Total Amount to €36 MJanuary 29, 2023 | finance.yahoo.comThe Worldwide Industrial Robotics Industry is Expected to Reach $43.9 Billion in 2027January 17, 2023 | finance.yahoo.comSee More Headlines CVRS Stock Analysis - Frequently Asked Questions How were Corindus Vascular Robotics' earnings last quarter? Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its earnings results on Tuesday, August, 7th. The medical equipment provider reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The medical equipment provider had revenue of $1.67 million for the quarter, compared to the consensus estimate of $3 million. How do I buy shares of Corindus Vascular Robotics? Shares of CVRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Corindus Vascular Robotics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Corindus Vascular Robotics investors own include Amarin (AMRN), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA), Helios and Matheson Analytics (HMNY) and NVIDIA (NVDA). Company Calendar Last Earnings8/07/2018Today9/20/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Medical Appliances & Equipment Sub-IndustryMedical Equipment Current SymbolNYSEAMERICAN:CVRS Previous SymbolNYSEMKT:CVRS CUSIPN/A CIKN/A Webwww.corindus.com Phone+1-508-6533335FaxN/AEmployees90Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares208,685,000Free FloatN/AMarket Cap$891.08 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report This page (NYSEAMERICAN:CVRS) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredTrump’s “Tax Free” Retirement StrategySince 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...Gold Safe Exchange | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corindus Vascular Robotics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Corindus Vascular Robotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.